menu
    • menu

    Company profile for Caplin Point Laboratories Limited

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Caplin Point Laboratories Ltd is a public listed company offering a wide range of pharmaceutical formulations with end to end operations in Latin America, South East Asia and Africa. Caplin holds over 1000 product registrations in 22 countries across the globe. In 2012, Caplin had taken a major step of entering into regulated markets by commencing construction of an integrated facility that would be in compliance with US FDA, ...
    Caplin Point Laboratories Ltd is a public listed company offering a wide range of pharmaceutical formulations with end to end operations in Latin America, South East Asia and Africa. Caplin holds over 1000 product registrations in 22 countries across the globe. In 2012, Caplin had taken a major step of entering into regulated markets by commencing construction of an integrated facility that would be in compliance with US FDA, ANVISA and UK MHRA norms for Liquid Injectables in Vials and Ampoules, Lyophilized products and Ophthalmic drugs. The plant is expected to be fully functional by early 2014.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Caplin Point Laboratories Limitedindia-flag Flag
    Country
    Country
    India
    Address
    Address
    NARBAVI3, Lakshmanan Street T.Nagar, Chennai-600 017 Tamil Nadu, INDIA.
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.caplinpoint.net/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Caplin Point Pharma's Injectables Facility Passes INVIMA Audit
    Caplin Point Pharma's Injectables Facility Passes INVIMA Audit

    15 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/caplin-point-laboratories-injectables-facility-completes-invima-audit-successfully-18555

    INDPHARMAPOST
    15 Dec 2025
    Share Share
    Caplin’s Generics Linezolid Receives Approval in US
    Caplin’s Generics Linezolid Receives Approval in US

    08 Dec 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219558

    FDA
    08 Dec 2025
    Share Share
    Caplin Point Laboratories' Subsidiary Acquires Land In Mexico
    Caplin Point Laboratories' Subsidiary Acquires Land In Mexico

    15 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/caplin-point-laboratories-subsidiary-acquires-land-in-mexico-18248

    INDPHARMAPOST
    15 Nov 2025
    Share Share
    Caplin Point Labs Posts Rs. 154.45 Cr PAT In Q2 FY26
    Caplin Point Labs Posts Rs. 154.45 Cr PAT In Q2 FY26

    09 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/caplin-point-laboratories-reports-q2-fy26-consolidated-pat-at-rs-15445-cr-18188

    INDPHARMAPOST
    09 Nov 2025
    Share Share
    FDA Approves Caplin Steriles' ANDA For Nicardipine Hydrochloride
    FDA Approves Caplin Steriles' ANDA For Nicardipine Hydrochloride

    24 Oct 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/caplin-steriles-receives-fda-approval-for-anda-nicardipine-hydrochloride-in-09-sodium-chloride-injection-18064

    INDPHARMAPOST
    24 Oct 2025
    Share Share
    Caplin Point Labs Reports Q1 FY26 Consolidated PAT of Rs. 152 Cr
    Caplin Point Labs Reports Q1 FY26 Consolidated PAT of Rs. 152 Cr

    08 Aug 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/caplin-point-laboratories-posts-q1-fy26-consolidated-pat-at-rs-15280-cr-17562

    INDPHARMAPOST
    08 Aug 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search